Table 2.
MiRNAs known to modulate chemoresistance through regulating autophagy.
| MiRNA | Target | MiRNA regulated autophagy | Autophagy regulated resistance | Drug | Reference |
|---|---|---|---|---|---|
| MiR-185 | Positively | Positively | (26) | ||
| MiR-494 | mTOR | Positively | Positively | Sorafenib | (27) |
| MiR-129-3p | Nrf2, mTOR | Positively | Positively | HDACis | (28) |
| MiR-142-3p | ATG5/ATG16L1 | Positively | Positively | Sorafenib | (29) |
| MiR-26b | LC3-II, P62 | Positively | Positively | 5-FU | (30) |
| MiR-26a/b | ULK1 | Negatively | Positively | Doxorubicin | (31) |
| MiR-101 | Negatively | Positively | Cisplatin | (32) | |
| MiR-199a-5p | Negatively | Positively | Cisplatin | (33) | |
| MiR-375 | Negatively | Positively | Sorafenib | (35) | |
| MiR-520b | ATG7 | Negatively | Positively | Doxorubicin | (36) |
| MiR-30a | Beclin1, ATG5 | Negatively | Positively | Sorafenib | (37) |
miRNAs, microRNAs; HDACis, histone deacetylase inhibitors; 5-FU, 5-fluorouracil.